A. Agouridis

High Doses of Rosuvastatin are Superior to Low Doses of Rosuvastatin Plus Fenofibrate or n-3 Fatty Acids in Mixed Dyslipidemia

M. Elisaf, T. Filippatos, V. Tsimihodimos, 2011, Lipids.

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω‐3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

M. Kostapanos, M. Elisaf, D. Mikhailidis, 2012, International journal of clinical practice.